Makela Jan 4
4 · GE HealthCare Technologies Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Makela Jan
CEO, Imaging
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2023-03-14$57.74/sh+5,967$344,535→ 75,687 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2023-03-14$40.40/sh+54,701$2,209,920→ 130,388 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2023-03-14$63.51/sh+240$15,242→ 69,720 total - Exercise/Conversion
Common Stock, par value $0.01 per share
2023-03-14$51.67/sh+4,037$208,592→ 134,425 total - Sale
Common Stock, par value $0.01 per share
2023-03-14$77.66/sh−64,945$5,043,629→ 69,480 total - Sale
Common Stock, par value $0.01 per share
2023-03-14$78.07/sh−5,684$443,750→ 63,796 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-14−240→ 0 totalExercise: $63.51Exp: 2030-03-02→ Common Stock, par value $0.01 per share (240 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-14−5,967→ 0 totalExercise: $57.74Exp: 2029-03-19→ Common Stock, par value $0.01 per share (5,967 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-14−4,037→ 0 totalExercise: $51.67Exp: 2029-04-11→ Common Stock, par value $0.01 per share (4,037 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2023-03-14−54,701→ 0 totalExercise: $40.40Exp: 2028-12-21→ Common Stock, par value $0.01 per share (54,701 underlying)
Footnotes (3)
- [F1]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $76.89 to $78.28, inclusive. The Reporting Person undertakes to provide to GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $77.95 to $78.23, inclusive. The Reporting Person undertakes to provide to GE HealthCare, any security holder of GE HealthCare, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
- [F3]Award of an employee stock option with respect to GE HealthCare common stock, of which 100% was fully exercisable prior to the transaction date.